242 related articles for article (PubMed ID: 37427403)
1. The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer's-related disease and preserving cognition.
Danziger R; Fuchs DT; Koronyo Y; Rentsendorj A; Sheyn J; Hayden EY; Teplow DB; Black KL; Fuchs S; Bernstein KE; Koronyo-Hamaoui M
Front Physiol; 2023; 14():1179315. PubMed ID: 37427403
[TBL] [Abstract][Full Text] [Related]
2. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
[TBL] [Abstract][Full Text] [Related]
3. A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models.
Rentsendorj A; Sheyn J; Fuchs DT; Daley D; Salumbides BC; Schubloom HE; Hart NJ; Li S; Hayden EY; Teplow DB; Black KL; Koronyo Y; Koronyo-Hamaoui M
Brain Behav Immun; 2018 Jan; 67():163-180. PubMed ID: 28860067
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.
Bernstein KE; Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Lopes DH; Shah KH; Bernstein EA; Fuchs DT; Yu JJ; Pham M; Black KL; Shen XZ; Fuchs S; Koronyo-Hamaoui M
J Clin Invest; 2014 Mar; 124(3):1000-12. PubMed ID: 24487585
[TBL] [Abstract][Full Text] [Related]
6. Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ
Zuroff LR; Torbati T; Hart NJ; Fuchs DT; Sheyn J; Rentsendorj A; Koronyo Y; Hayden EY; Teplow DB; Black KL; Koronyo-Hamaoui M
Front Immunol; 2020; 11():1449. PubMed ID: 32765504
[TBL] [Abstract][Full Text] [Related]
7. Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.
Zuroff L; Daley D; Black KL; Koronyo-Hamaoui M
Cell Mol Life Sci; 2017 Jun; 74(12):2167-2201. PubMed ID: 28197669
[TBL] [Abstract][Full Text] [Related]
8. Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.
Möhle L; Israel N; Paarmann K; Krohn M; Pietkiewicz S; Müller A; Lavrik IN; Buguliskis JS; Schott BH; Schlüter D; Gundelfinger ED; Montag D; Seifert U; Pahnke J; Dunay IR
Acta Neuropathol Commun; 2016 Mar; 4():25. PubMed ID: 26984535
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of myeloid angiotensin-converting enzyme (ACE) reduces atherosclerosis.
Okwan-Duodu D; Weiss D; Peng Z; Veiras LC; Cao DY; Saito S; Khan Z; Bernstein EA; Giani JF; Taylor WR; Bernstein KE
Biochem Biophys Res Commun; 2019 Dec; 520(3):573-579. PubMed ID: 31615657
[TBL] [Abstract][Full Text] [Related]
10. Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ
Li S; Hayden EY; Garcia VJ; Fuchs DT; Sheyn J; Daley DA; Rentsendorj A; Torbati T; Black KL; Rutishauser U; Teplow DB; Koronyo Y; Koronyo-Hamaoui M
Front Immunol; 2020; 11():49. PubMed ID: 32082319
[TBL] [Abstract][Full Text] [Related]
11. Myeloid cell ACE shapes cellular metabolism and function in PCSK-9 induced atherosclerosis.
Cao D; Saito S; Xu L; Fan W; Li X; Ahmed F; Jovanovic P; Shibata T; Che M; Bernstein EA; Gianni J; Divakaruni AS; Okwan-Duodu D; Khan Z; Riera CE; Chen F; Bernstein KE
Front Immunol; 2023; 14():1278383. PubMed ID: 37928535
[TBL] [Abstract][Full Text] [Related]
12. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
Martin E; Boucher C; Fontaine B; Delarasse C
Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
[TBL] [Abstract][Full Text] [Related]
13. Microglia Express Insulin-Like Growth Factor-1 in the Hippocampus of Aged APP
Myhre CL; Thygesen C; Villadsen B; Vollerup J; Ilkjær L; Krohn KT; Grebing M; Zhao S; Khan AM; Dissing-Olesen L; Jensen MS; Babcock AA; Finsen B
Front Cell Neurosci; 2019; 13():308. PubMed ID: 31417357
[TBL] [Abstract][Full Text] [Related]
14. Impact of IL-21-associated peripheral and brain crosstalk on the Alzheimer's disease neuropathology.
Agrawal S; Baulch JE; Madan S; Salah S; Cheeks SN; Krattli RP; Subramanian VS; Acharya MM; Agrawal A
Cell Mol Life Sci; 2022 Jun; 79(6):331. PubMed ID: 35648273
[TBL] [Abstract][Full Text] [Related]
15. ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease.
Koronyo-Hamaoui M; Shah K; Koronyo Y; Bernstein E; Giani JF; Janjulia T; Black KL; Shi PD; Gonzalez-Villalobos RA; Fuchs S; Shen XZ; Bernstein KE
Curr Hypertens Rep; 2014 Jul; 16(7):444. PubMed ID: 24792094
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype.
Minter MR; Moore Z; Zhang M; Brody KM; Jones NC; Shultz SR; Taylor JM; Crack PJ
Acta Neuropathol Commun; 2016 Jul; 4(1):72. PubMed ID: 27400725
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin Converting Enzyme (ACE) expression in microglia reduces amyloid β deposition and neurodegeneration by increasing SYK signaling and endolysosomal trafficking.
Gomez AR; Byun HR; Wu S; Muhammad AG; Ikbariyeh J; Chen J; Muro A; Li L; Bernstein KE; Ainsworth R; Tourtellotte WG
bioRxiv; 2024 May; ():. PubMed ID: 38712251
[TBL] [Abstract][Full Text] [Related]
18. Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow.
Keene CD; Chang RC; Lopez-Yglesias AH; Shalloway BR; Sokal I; Li X; Reed PJ; Keene LM; Montine KS; Breyer RM; Rockhill JK; Montine TJ
Am J Pathol; 2010 Jul; 177(1):346-54. PubMed ID: 20522650
[TBL] [Abstract][Full Text] [Related]
19. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K
J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831
[TBL] [Abstract][Full Text] [Related]
20. TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease.
Song M; Jin J; Lim JE; Kou J; Pattanayak A; Rehman JA; Kim HD; Tahara K; Lalonde R; Fukuchi K
J Neuroinflammation; 2011 Aug; 8():92. PubMed ID: 21827663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
